Elkfork Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$320K Buy
7,854
+238
+3% +$10.3K 0.01% 708
2019
Q2
$367K Buy
7,616
+884
+13% +$46.5K 0.01% 675
2019
Q1
$422K Buy
6,732
+136
+2% +$9.34K 0.01% 603
2018
Q4
$394K Buy
6,596
+272
+4% +$16.3K 0.01% 588
2018
Q3
$408K Buy
6,324
+1,394
+28% +$77.8K 0.01% 652
2018
Q2
$222K Hold
4,930
0.01% 758
2018
Q1
$153K Hold
4,930
﹤0.01% 854
2017
Q4
$147K Buy
4,930
+1,190
+32% +$34.5K ﹤0.01% 862
2017
Q3
$124K Buy
3,740
+544
+17% +$18.8K ﹤0.01% 852
2017
Q2
$107K Buy
3,196
+1,326
+71% +$39.6K ﹤0.01% 842
2017
Q1
$54K Buy
+1,870
New +$46.3K ﹤0.01% 881

Other funds holding BEAT

Elkfork Partners's BEAT Position: Q3 2019 in Review

Elkfork Partners increased its BioTelemetry, Inc. (BEAT) stake by 3.1% in Q3 2019, buying an estimated $10.3K and bringing the position to 7,854 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #708.

Elkfork Partners first reported a position in BEAT in Q1 2017 and has held it in 11 quarters since. The position peaked at $422K in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Elkfork Partners held 7,854 shares of BioTelemetry, Inc. worth $320K as of Q3 2019.
  • Elkfork Partners bought 238 BioTelemetry, Inc. shares in Q3 2019, an estimated $10.3K.
  • BioTelemetry, Inc. made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #708 holding.
  • Elkfork Partners first reported a position in BioTelemetry, Inc. in Q1 2017 and has held it in 11 quarters since.
  • Elkfork Partners's BioTelemetry, Inc. position peaked at $422K in Q1 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.